bis research
BIS healthcare vertical offers intelligence in the healthcare technology market for precision medicine, robotics and imaging, life sciences and biopharma, medical devices, digital health, and other emerging healthcare technologies, covering the entire industry spectrum.
A liquid biopsy helps physicians to analyze tumor-related information through a simple blood test. As researchers are generating data that have the potential to lead to unprecedented biological insight, albeit at the cost of the greater complexity of data analysis. Increasing investments in R&D of liquid biopsy products and services and various research fundings is one of the major opportunities in the global liquid biopsy market.
Urgent care apps are smartphone applications intended to serve patients seeking urgent care by connecting them to a relevant specialist and facilitating further courses of action such as diagnosis, treatment, and monitoring. Treatment can be offered remotely via text/audio/video calls or help can be arranged to usher the patient to the nearest hospital.
The market for spine X-Ray and CT equipment is quickly expanding as more CT scans and X-Rays are employed for imaging of vertebral fractures, spinal infections, and spinal malignancies. Furthermore, the incorporation of artificial intelligence (AI) is accelerating the industry's growth.
Because of its advanced technology, artificial intelligence is quickly becoming one of the most passionately debated topics in healthcare.
The emerging mental health devices and platforms market was estimated at $1,362.4 Million in 2019 and is expected to grow at a CAGR of 24.69% during the forecast period from 2021 to 2030. Possible opportunities that can boost the growth of the market include development of portable mental health devices and development of novel therapies for mental health treatment.
Surgical instrument tracking devices have revolutionized tracking and locating medical devices through the introduction of technologically advanced products and their increased adoption among their end users. Major manufacturers of these advanced technologies are located mainly in North America and Europe.
The burden of breast cancer incidence and mortality is growing alarmingly, which can be attributed to the rising population coupled with socioeconomic risk factors that impact breast cancer prevalence. SERDs have shown significant potential to treat patients with endocrine-resistant breast cancer and naive patients with breast cancer.
Molecular diagnostics is described as diagnostic test that identifies variations in genes, ribonucleic acids (RNAs), and proteins that highlight whether a person is susceptible to a specific disease or is diagnosed with that disease. The molecular diagnostics market has made significant strides in the research, which has enabled the dissemination of treatment that has revolutionized the healthcare sector.
The growth in the global serum-free media market is expected to be driven by factors such as the low risk of contamination in the media
PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages.
Robotic-assisted imaging technology involves imaging and robotics technology to create a computer-controlled and self-powered mechanism that is simple to handle. Primarily utilized in the medical sector, image-guided procedures can play a critical role in performing robot-assisted surgeries.
North America is expected to dominate the robotic-assisted imaging technologies market throughout the period 2021-2030.
Constrained peptide therapeutics demonstrates a novel and selective yet safe mode of action for a wide range of indications. The existing and future development of constrained peptide drugs will continue to burgeon upon the strengths of constrained peptides and innovative technologies employed in the discovery and development, including peptide drug conjugates, multifunctional peptides, and cell-penetrating peptides.
In recent years, the preference for serum-free media for cell culture has increased over traditional animal-derived media.
the worldwide aseptic pharma processing market was worth $10,633.3 million in 2020 and is predicted to reach $24,364.0 million by 2031
Wondering how the in-space economy is going to evolve and what will be the significance of in-orbit refueling services in that regard?
BIS Research is organizing an extensive #webinar on "In-Orbit Space Refueling" that will answer all your questions.
The webinar will be hosted by the team of lead research analysts (Aerospace & SpaceTech) at BIS Research, along with our guest presenter Daniel Faber, CEO of Orbit Fab
The global nucleic acid isolation and purification market was estimated at $2,304.7 Million in 2020 and is expected to grow at a CAGR of 7.20% from 2021 to 2031. The market for nucleic acid isolation and purification has been deemed to benefit from COVID-19's current effects. The need for DNA/RNA isolation and purification kits has expanded significantly due to the current necessity for sophisticated and high-throughput solutions for sample testing.
The pharmaceutical quality management software (QMS) systems offer services in various areas of quality such as corrective action preventive action (CAPA) management, document management, regulatory and compliances management, and supplier quality management, among others.
As phosphoramidites serve as raw materials for DNA synthesis, the global phosphoramidite market is subjected to grow significantly in the DNA and RNA oligonucleotide industry.
Technological advancements anticipated from 2022 to 2031 are expected to play a crucial role in deciding the future of the big data in healthcare market and the level of adoption. The COVID-19 pandemic has played a key role in increasing the adoption rate of connected devices and also brought a of urgency towards achieving higher adoption rates.
Digital PCR technology has emerged to be an integrative aspect of healthcare practices. Digital PCR in Obstetrical and Gynecological Diseases/
Making the leap from manual to automated NGS library preparation has many advantages. Automated library preparations are more effective, quicker, and less prone to human error.
companion diagnostics refers to the process of developing the targeted medicine along with the biomarker-based testing. Companion diagnostics also aid in locating patient-related data and make it easier to utilise focused therapies.
The images of vasculature help understand how tissues develop a disorder and respond to a particular treatment
The epigenetics industry has tremendous growth potential due to highly opportunistic trends like the quick acceptance of epigenetics in the treatment of cancer, heart disease, and liver cirrhosis in healthcare settings. The rise of epigenetics has resulted in a growing need for testing assays developed by firms in this sector to enable improved outcomes on the rising occurrence of cancer.
The market for spine X-ray and CT devices is rapidly growing, with an increasing number of X-rays and CT scans used in imaging of vertebral fractures, spinal infections, and spinal tumors, among others.
North America is expected to be the most lucrative region for the global spine X-ray and computed tomography market due to advanced healthcare infrastructure and a high focus on research and development activities.
The healthcare industry is evolving, with a focus on more informative advanced tools rather than traditional approaches. Robotic-assisted imaging technologies, for example, have been created to provide more precise and optimal diagnostic results.
Robotic-assisted imaging systems are quickly becoming the most lucrative opportunities for major corporations, with many companies focusing solely on developing multiple diagnostic and treatment-focused products.
